(PATH) Uipath - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90364P1057

Automation, Robot, AI, Workflow, Mining

Systems Software
Market Cap in USD: 9,267m

IPO / Inception: 2021-04-21
12m vs SPY: 3.10%

EPS (Earnings per Share)

EPS CAGR: 36.37%
EPS Trend: 62.6%

Last SUE: 0.37
Qual. Beats: 0

Revenue

Rev. CAGR: 9.78%
Rev. Trend: 84.2%

Last SUE: 2.05
Qual. Beats: 3

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	64.5%
Value at Risk 5%th	96.0%
Relative Tail Risk	-9.59%

Reward TTM
Sharpe Ratio	0.59
Alpha	-4.16
CAGR/Max DD	0.08

Character TTM
Hurst Exponent	0.485
Beta	1.379
Beta Downside	1.033

Drawdowns 3y
Max DD	63.58%
Mean DD	34.07%
Median DD	40.48%

Description: PATH Uipath January 09, 2026

UiPath Inc. (NYSE: PATH) offers a cloud-native, end-to-end automation platform that combines low-code RPA, AI/ML/NLP, and API integration into a single workflow engine. The suite includes “Automation Cloud” for rapid deployment without on-premise infrastructure, a process-mining module that maps digital footprints, and analytics that track and forecast automation performance. Its primary markets span financial services, healthcare, manufacturing, retail, and the public sector, with a geographic focus on the United States, Romania, the United Kingdom, and the Netherlands.

Key recent metrics (FY 2023): revenue $1.86 bn (+33 % YoY), subscription ARR of $2.3 bn (up 38 % YoY), and a gross margin of ~78 %. The RPA market is projected to grow at a CAGR of ~30 % through 2028, driven by enterprise pressure to cut operating costs and the broader AI-automation convergence. A material risk factor is the concentration of revenue in large-enterprise contracts, which can cause earnings volatility if renewal rates dip.

For a deeper, data-driven valuation perspective, you may find the analytics on ValueRay useful for benchmarking UiPath against peers and assessing scenario-based upside potential.

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (229.7m TTM) > 0 and > 6% of Revenue (6% = 93.2m TTM)

FCFTA 0.11 (>2.0%) and ΔFCFTA -0.84pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 78.43% (prev 104.9%; Δ -26.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.12 (>3.0%) and CFO 334.9m > Net Income 229.7m (YES >=105%, WARN >=100%)

Net Debt (-671.6m) to EBITDA (25.9m) ratio: -25.89 <= 3.0 (WARN <= 3.5)

Current Ratio 2.54 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (544.7m) change vs 12m ago -3.24% (target <= -2.0% for YES)

Gross Margin 83.16% (prev 83.20%; Δ -0.04pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 55.87% (prev 52.99%; Δ 2.88pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -0.57 (EBITDA TTM 25.9m / Interest Expense TTM -40.1m) >= 6 (WARN >= 3)

Altman Z'' -1.15

(A) 0.42 = (Total Current Assets 2.01b - Total Current Liabilities 788.7m) / Total Assets 2.90b

(B) -0.63 = Retained Earnings (Balance) -1.81b / Total Assets 2.90b

(D) -1.83 = Book Value of Equity -1.78b / Total Liabilities 971.4m

Total Rating: -1.15 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 61.12

1. Piotroski 6.0pt

2. FCF Yield 3.92%

3. FCF Margin 20.06%

4. Debt/Equity 0.04

5. Debt/Ebitda -25.89

6. ROIC - WACC (= -9.90)%

7. RoE 12.88%

8. Rev. Trend 84.15%

9. EPS Trend 62.63%

What is the price of PATH shares?

As of January 14, 2026, the stock is trading at USD 15.97 with a total of 49,466,106 shares traded.
Over the past week, the price has changed by -7.85%, over one month by -1.18%, over three months by -6.83% and over the past year by +24.47%.

Is PATH a buy, sell or hold?

Uipath has received a consensus analysts rating of 3.17. Therefor, it is recommend to hold PATH.

Strong Buy: 3
Buy: 1
Hold: 18
Sell: 1
Strong Sell: 1

What are the forecasts/targets for the PATH price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	16.3	1.9%
Analysts Target Price	16.3	1.9%
ValueRay Target Price	15.9	-0.3%

PATH Fundamental Data Overview January 08, 2026

P/E Trailing = 41.2619
P/E Forward = 21.3675
P/S = 5.9669
P/B = 4.4539
P/EG = 0.6107
Beta = 1.079
Revenue TTM = 1.55b USD
EBIT TTM = 22.7m USD
EBITDA TTM = 25.9m USD
Long Term Debt = 82.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.59m USD (from shortTermDebt, last fiscal year)
Debt = 72.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -671.6m USD (from netDebt column, last quarter)
Enterprise Value = 7.94b USD (9.27b + Debt 72.0m - CCE 1.40b)
Interest Coverage Ratio = -0.57 (Ebit TTM 22.7m / Interest Expense TTM -40.1m)
EV/FCF = 25.49x (Enterprise Value 7.94b / FCF TTM 311.6m)
FCF Yield = 3.92% (FCF TTM 311.6m / Enterprise Value 7.94b)
FCF Margin = 20.06% (FCF TTM 311.6m / Revenue TTM 1.55b)
Net Margin = 14.79% (Net Income TTM 229.7m / Revenue TTM 1.55b)
Gross Margin = 83.16% ((Revenue TTM 1.55b - Cost of Revenue TTM 261.6m) / Revenue TTM)
Gross Margin QoQ = 83.26% (prev 82.20%)
Tobins Q-Ratio = 2.74 (Enterprise Value 7.94b / Total Assets 2.90b)
Interest Expense / Debt = 25.19% (Interest Expense 18.1m / Debt 72.0m)
Taxrate = 5.64% (-4.41m / -78.1m)
NOPAT = 21.4m (EBIT 22.7m * (1 - 5.64%))
Current Ratio = 2.54 (Total Current Assets 2.01b / Total Current Liabilities 788.7m)
Debt / Equity = 0.04 (Debt 72.0m / totalStockholderEquity, last quarter 1.92b)
Debt / EBITDA = -25.89 (Net Debt -671.6m / EBITDA 25.9m)
Debt / FCF = -2.16 (Net Debt -671.6m / FCF TTM 311.6m)
Total Stockholder Equity = 1.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.26% (Net Income 229.7m / Total Assets 2.90b)
RoE = 12.88% (Net Income TTM 229.7m / Total Stockholder Equity 1.78b)
RoCE = 1.22% (EBIT 22.7m / Capital Employed (Equity 1.78b + L.T.Debt 82.0m))
RoIC = 1.20% (NOPAT 21.4m / Invested Capital 1.78b)
WACC = 11.10% (E(9.27b)/V(9.34b) * Re(11.0%) + D(72.0m)/V(9.34b) * Rd(25.19%) * (1-Tc(0.06)))
Discount Rate = 11.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.99%
[DCF Debug] Terminal Value 66.95% ; FCFF base≈310.4m ; Y1≈300.3m ; Y5≈297.4m
Fair Price DCF = 8.61 (EV 3.29b - Net Debt -671.6m = Equity 3.97b / Shares 460.4m; r=11.10% [WACC]; 5y FCF grow -4.47% → 2.90% )
EPS Correlation: 62.63 | EPS CAGR: 36.37% | SUE: 0.37 | # QB: 0
Revenue Correlation: 84.15 | Revenue CAGR: 9.78% | SUE: 2.05 | # QB: 3
EPS next Quarter (2026-04-30): EPS=0.15 | Chg30d=-0.003 | Revisions Net=+0 | Analysts=18
EPS next Year (2027-01-31): EPS=0.76 | Chg30d=+0.005 | Revisions Net=+6 | Growth EPS=+13.1% | Growth Revenue=+9.2%

Additional Sources for PATH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle